Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 4

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 4
---
 working
                                            capital.

January
2025 Offering

On January 28, 2025, we entered into a securities
purchase agreement (the “January 2025 Securities Purchase Agreement”) with certain institutional investors (the “January
2025 Purchasers”) pursuant to which the Company sold, in a registered direct offering an aggregate of 204,312 shares (the “January
2025 Shares”) of common stock at a purchase price of $5.105 per share in a registered direct offering priced at-the-market under
the rules of The Nasdaq Stock Market LLC (“Nasdaq”).

The
January 2025 Shares were offered pursuant to a “shelf” registration statement on Form S-3 (Registration No. 333-280796),
which was declared effective by the Securities and Exchange Commission (the “SEC”) on July 18, 2024 as supplemented by a
prospectus supplement dated January 28, 2025, filed with the SEC on January 30, 2025, and accompanying base prospectus, pursuant to Rule
424(b)(5) promulgated under the Securities Act of 1933, as amended (the “Securities Act”).

In
                                            a concurrent private placement, the Company also issued to the January 2025 Purchasers unregistered
                                            warrants (the “January 2025 Warrants”) to purchase up to an aggregate of 408,621
                                            shares of common stock at an exercise price of $3.855 per share. The January 2025 Warrants
                                            are exercisable upon issuance and expire twenty-four months from the date of issuance. 

Pursuant
                                            to the January 2025 Securities Purchase Agreement, the Company is required to file a registration
                                            statement with the SEC within 45 days after the date of the January 2025 Securities Purchase
                                            Agreement to register the shares underlying the January 2025 Warrants under the Securities
                                            Act. The Company shall use commercially reasonable efforts to cause such registration statement
                                            to become effective within 75 days following the closing date of the January 2025 Offering
                                            and to keep such registration statement effective at all times until no January 2025 Purchaser
                                            owns any January 2025 Warrants or shares underlying the January 2025 Warrants issuable upon
                                            exercise thereof.

Any
                                            holder will not have the right to exercise any portion of the January 2025 Warrants if the
                                            holder (together with